Sepúlveda, J. M., Valiente, M., Martínez-García, M., Pineda, E., Vaz-Salgado, M. Ã., Vico, M. R., Velilla, G., Mazariegos-Rubi, M., Valduvieco, I., Henriques, M. C., Cano, L., Marcus, S. G. (2025). Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Preliminary results of phase Ib/II CAN-201 NDG trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2069